Company Overview and News

 
TransCanada (TRP) Q2 2017 Results - Earnings Call Transcript

2017-07-29 seekingalpha
Good day, ladies and gentlemen. Welcome to the TransCanada Corporation 2017 Second Quarter Results Conference Call.
Upvote Downvote

 
Fitness and food replacing fashion and finance on high streets

2017-04-12 news.sky
A report says clothing stores and banks are being replaced by coffee shops and vaping outlets on the UK's high streets.
Upvote Downvote

 
SOTIO a.s.: LDC and SOTIO License and Collaboration Agreement

2017-04-11 marketwired
Dortmund, Germany and Prague, Czech Republic, April 11, 2017 - The Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH (MI) and SOTIO a.s. have signed a collaboration and license agreement providing SOTIO with exclusive rights to an oncology program addressing a novel target in tumor metabolism. It was discovered at the Max Planck Institute for Biology of Ageing and jointly advanced by the LDC and Max Planck scientists into drug discovery.
Upvote Downvote

 
Weinberg Foundation Dedicates 12th and 13th Libraries in Baltimore City Public Schools

2017-01-23 prnewswire
BALTIMORE, Jan. 23, 2017 The Harry and Jeanette Weinberg Foundation, one of the largest private foundations in the United States, today will host a celebration marking the grand opening of the 12th and 13th libraries renovated as part of the Baltimore Elementary and Middle School Library Project. The newly renovated spaces are located at Hampden Elementary/Middle and George Washington Elementary, where today's official celebration will take place:
Upvote Downvote

 
Shop openings slump as big UK retailers scale back expansion plans | Business | The Guardian

2016-09-20 theguardian
Pre-EU referendum jitters blamed for 15% decline in high street shop openings as vacancy rates rise for first time since 2012
Upvote Downvote

 
SGX confirms Swiber probe

2016-09-15 business.asiaone
The Singapore Exchange has confirmed investigations into developments at Swiber Holdings, saying that the probe is ongoing.
Upvote Downvote

 
Maverick Capital Warns Of S&P 500 Valuations - ValueWalk

2016-08-08 valuewalk
Maverick Capital likes the second half of 2016 – and the firm’s leveraged fund benefited most during the period. The Maverick Levered fund was up 5.4% in the second quarter, according to a letter to investors viewed by ValueWalk.  The Long Enhanced and Long programs also benefited during otherwise back and forth stock market period while the Select program was down slightly.
Upvote Downvote

 
Does premature Paris climate deal risk a painful birth?

2016-04-18 channelnewsasia
BARCELONA (Thomson Reuters Foundation) - When ministers and climate change negotiators from the world's poorest countries gathered in Kinshasa recently, they were dismayed at a proposal from the Third World Network (TWN) urging them not to rush into signing the new Paris climate agreement at a U.N. ceremony this week.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...